Paid Clinical Trials in Long Island City, NY
As of August 2026, 22 paid clinical trials are recruiting in Long Island City, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Long Island City offers studies at sites including NYC Research INC for conditions such as Advanced Breast Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Advanced or Metastatic Renal Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Long Island City
Filter results
0 clinical trials
·Clear filters·Top Research Study Locations in Long Island City
Researchers run research studies in Long Island City, NY at 15 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| NYC Research INC | Obesity, Osteoarthritis, Overweight | 4 |
| Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy | Advanced Breast Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 3 |
| Decentralized Site - Virtual/Remote (NY, USA) | Caries, Diabetes Type 2, Periodontal Disease | 1 |
| Long Island Vitreoretinal Consultants - Westbury | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| MSK Cancer Center | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations | 1 |
| Memorial Sloan Kattering Cancer Centre- Investigational Drug Service Pharmacy | Urothelial Carcinoma | 1 |
| Memorial Sloan Kettering | Metastatic HER2-positive Breast Cancer | 1 |
| Memorial Sloan Kettering Cancer Center | Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer, Unresectable Head and Neck Squamous Cell Carcinoma | 1 |
| Memorial Sloan Kettering Cancer Center (IDS Pharmacy) | Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC) | 1 |
| Mount Sinai Queens | Clostridoides Difficile Associated Disease | 1 |
| NYC Research Inc. | Type 1 Diabetes Mellitus With Hypoglycemia | 1 |
| Northwell Health | GBM, Glioblastoma | 1 |
| Research | Hypertriglyceridemia | 1 |
| START | GI Cancers | 1 |
| Start - Ny | Endometrial Cancer, PROC, Platinum Resistant Ovarian Cancer | 1 |
Active & Upcoming Studies in Long Island City (2026)
Recruiting trials in Long Island City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (8 active studies)
- A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. · Phase 1 · Whitehawk Therapeutics, Inc.
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · Phase 1, Phase 2 · Pfizer
Diabetes & metabolic (6 active studies)
- Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes · Phase 4 · Colgate Palmolive
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight · Phase 3 · Eli Lilly and Company
Eye & vision (1 active study)
- A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio · Phase 2 · Apellis Pharmaceuticals, Inc.
Common conditions studied in Long Island City
- Advanced Breast Cancer (1 active study)
- Advanced Renal Cell Carcinoma (1 active study)
- Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations (1 active study)
- Advanced or Metastatic Renal Cell Carcinoma (1 active study)
- Cancer of the Prostate (1 active study)
- Carcinoma, Renal Cell (1 active study)
Leading research sponsors in Long Island City
- Pfizer
- Eli Lilly and Company
- Alpheus Medical, Inc.
- Apellis Pharmaceuticals, Inc.
- Arrowhead Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Long Island City?
There are approximately 22 recruiting clinical trials in Long Island City, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Long Island City pay participants?
Most recruiting trials in Long Island City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Long Island City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Long Island City?
The most common conditions under active study in Long Island City include Advanced Breast Cancer (1), Advanced Renal Cell Carcinoma (1), Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations (1), Advanced or Metastatic Renal Cell Carcinoma (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Long Island City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Long Island City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Long Island City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Long Island City?
Recruiting research sites in Long Island City include NYC Research INC, Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Decentralized Site - Virtual/Remote (NY, USA), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Long Island City right now?
The largest active categories in Long Island City are Cancer & tumors (8), Diabetes & metabolic (6), Eye & vision (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.